Related Experiment Video

Updated: Jul 7, 2026

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection
08:16

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection

Published on: July 21, 2022

Caspases as therapeutic targets

B Howley1, H O Fearnhead

  • 1Department of Pharmacology and Therapeutics, National University of Ireland, Galway, Ireland.

Journal of Cellular and Molecular Medicine
|February 27, 2008
PubMed

Insights

Small molecules targeting caspases offer new treatments for apoptosis and inflammation. This review explores caspase disorders and highlights caspase-1 inhibition as a promising therapeutic avenue.

Area of Science:

  • Biochemistry and Molecular Biology
  • Pharmacology
  • Immunology

Background:

  • Caspases are critical enzymes regulating apoptosis (programmed cell death) and inflammatory pathways.
  • Dysregulated caspase activity is implicated in various diseases, including neurodegenerative and autoinflammatory disorders.
  • Targeting caspases presents a novel therapeutic strategy for these conditions.

Purpose of the Study:

  • To review caspase-associated disorders.
  • To focus on caspase-1 inhibition as a potential therapeutic approach.
  • To discuss challenges in developing effective and safe caspase-modulating drugs.

Main Methods:

  • Literature review of scientific articles and clinical studies.
  • Analysis of caspase function in disease pathogenesis.
  • Evaluation of therapeutic strategies targeting caspases, particularly caspase-1.

Main Results:

  • Caspase deregulation is a common feature in numerous pathological conditions.
  • Caspase-1 inhibition shows significant therapeutic potential for specific inflammatory and autoimmune diseases.
  • Several challenges exist in achieving targeted delivery and minimizing off-target effects of caspase inhibitors.

Conclusions:

  • Modulating caspase activity is a viable therapeutic strategy for apoptosis and inflammation-related diseases.
  • Caspase-1 inhibition represents a promising avenue for treating specific disorders.
  • Overcoming development hurdles is crucial for realizing the clinical potential of caspase therapeutics.

More Related Videos

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches05:56

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches

Published on: October 13, 2022

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation08:47

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

Published on: March 5, 2018

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...